STAT3 and metabolic disease: The overexpression of PTPN2 was suggested to inhibit the differentiation of Th17 cells and promote the differentiation of Treg cells by downregulating Stat3, which further confirmed that an imbalance of the Th17/Treg cell ratio can mediate the occurrence of obesity-related inflammation and metabolic disorders.